Rebecca Terry
Gynecology · Louisville, KYNPI 1871688408
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,557 of the $2,842 with a category attached, or 90.0%. It is spread thinly across 27 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,218 and has fallen 98.7% since, to $16 in 2024.
Across 118 payments — averaging $24.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$577
- Astellas Pharma US Inc$527
- Mayne Pharma Commercial LLC$311
- Aspira Women's Health Inc$296
- Myovant Sciences Inc.$264
- Radius Health, Inc.$87
- plus $780 from 21 others
What the payments were for
- Food & beverage$2,55790%
- Education$28510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYFEMBREE$125
- Veozah$125
- NEXTSTELLIS$122
- Orilissa$102
How this compares
$2,842 in reported general payments places this provider in the 85th percentile of 42 gynecology providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 41 | $4,450 |
| ImvexxyEstradiol | 16 | $3,386 |
| Estradiol | 45 | $1,562 |
| ProgesteroneProgesterone, Micronized | 18 | $727 |
| ValacyclovirValacyclovir Hcl | 11 | $188 |
| Alendronate Sodium | 25 | $179 |
| Medroxyprogesterone Acetate | 13 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Therapeuticsmd, Inc.Imvexxy | $36 | $3,38616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 42 gynecology providers in Kentucky.
Other gynecology in Louisville
- Lori WarrenLouisville$218K
- Mark DasselLouisville$23K
- Emily HenryLouisville$3K
- Nancy NewmanLouisville$3K
- Susan HertweckLouisville$1K
- Alexandria ConnorLouisville$1K
- Jacqueline LomboyLouisville$517
- Robert ZollerLouisville$376
- Glenn McCoyLouisville$355
- Susan BornsteinLouisville$165
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.